Adjuvant Large B-Cell Lymphoma
- Result Type
- clinical trial
Consolidation of First-Line MRD+ Remission with Cema-cel in Patients with LBCL (ALPHA3)
Get personalized, coordinated care across Northern California through the Sutter network.
View Patient ResourcesMake appointments, message your doctor and more through our patient portal.
Enroll NowAccess award-winning, comprehensive primary and specialty care for your whole family.
View All ServicesOur contributions to medical research and education lead to better healthcare outcomes.
Research at SutterJoin our robust training programs led by nationally known healthcare leaders.
Explore OpportunitiesExplore the ways we provide innovative, compassionate care through our network.
Learn About Sutter HealthShape the future of healthcare and build your career within our diverse teams.
Find JobsGet personalized, coordinated care across Northern California through the Sutter network.
View Patient ResourcesMake appointments, message your doctor and more through our patient portal.
Enroll NowMake appointments, message your doctor and more through our patient portal.
Enroll NowAccess award-winning, comprehensive primary and specialty care for your whole family.
View All ServicesOur contributions to medical research and education lead to better healthcare outcomes.
Research at SutterJoin our robust training programs led by nationally known healthcare leaders.
Explore OpportunitiesJoin our robust training programs led by nationally known healthcare leaders.
Explore OpportunitiesExplore the ways we provide innovative, compassionate care through our network.
Learn About Sutter HealthShape the future of healthcare and build your career within our diverse teams.
Find JobsShape the future of healthcare and build your career within our diverse teams.
Find JobsYou are viewing results from Research and Clinical Trials.
13results found for:
Consolidation of First-Line MRD+ Remission with Cema-cel in Patients with LBCL (ALPHA3)
Status: Active, Recruiting
Ashwagandha for Cognitive Dysfunction
Status: Active, Recruiting
Protocol For A Research Database For Hematopoietic Stem Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries
Status: Active, Recruiting
The purpose of this study is to find out how genetics, biologics and behavior might contribute to
Status: Active, Recruiting
Connect® MDS/AML Disease Registry
Status: Active, Recruiting
Imaging of T-cell Activation With [18F]F-AraG in Advanced Non Small Cell Lung Cancer
Status: Active, Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma
Status: Active, Recruiting
A Phase 2 Study of Inotuzumab Ozogamicin in Children and Young Adults with Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL)
Status: Active, Not Recruiting
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/?Refractory Mantle Cell Lymphoma (GLOBRYTE)
Status: Active, Recruiting
A Phase 3 Randomized Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Particip
Status: Active, Recruiting
Check-ups, screenings and sick visits for adults and children.
Expertise and advanced technologies in all areas of medicine.
For serious accidents, injuries and conditions that require immediate medical care.
After-hours, weekend and holiday services.
Convenient walk-in care clinics for your non-urgent health needs.